CTU: A PHASE 1/2, RANDOMIZED, DOUBLEMASKED, PLACEBO-CONTROLLED, MULTICENTER STUDY TO ASSESS THE SAFETY, PHARMACOKINETICS, AND EFFICACY OF AMG 732 IN HEALTHY SUBJECTS AND SUBJECTS WITH MODERATE-TO SEVERE ACUTE THYROID EYE DISEASE
Tumuluri, Krishna (Primary Chief Investigator)
Armstrong, Emilia (Clinical Trial Unit Staff)
Quinlan, Gabriel (Clinical Trial Unit Staff)
Chapman, Nicola (Clinical Trial Unit Staff)
Garcia, Michelle (Clinical Trial Unit Staff)
Martin, Lewis (Clinical Trial Unit Staff)
Lawrie, Angus (Clinical Trial Unit Staff)
Delahunt Smoleniec, Jacqui (Clinical Trial Unit Staff)